Skip to main content
. 2021 Oct 20;12:773352. doi: 10.3389/fimmu.2021.773352

Figure 1.

Figure 1

The clinical phenotypes of anti-MDA5 dermatomyositis. Anti-MDA5 dermatomyositis can be divided into three clinical phenotypes with varying degrees of pulmonary damage, which is inversely correlated with the survival. RP-ILD, rapidly progressive interstitial lung disease.